Literature DB >> 6642406

Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives.

S Tarpila, M Kekki, I M Samloff, P Sipponen, M Siurala.   

Abstract

The prevalence of antral and body gastritis was determined in 30 duodenal ulcer patients and in 143 of their first-degree relatives, and compared by conventional mathematical and stochastic analyses with data on gastritis in a representative Finnish population sample. For conventional analysis, the controls for the duodenal ulcer patients and for the duodenal ulcer relatives, were matched for age and sex. For stochastic analysis, the duodenal ulcer patients and their 99 siblings were compared with the total control population of 434 subjects. The prevalence of gastritis affecting mainly the antral mucosa, and both antral and body mucosa to a similar extent was significantly higher in duodenal ulcer patients than in both controls and in relatives. The prevalence of antral and body gastritis in DU relatives and their controls was similar. However, the prevalence of subjects with normal antral and body mucosa was significantly lower. Stochastic analysis revealed more rapid progression of antral gastritis with age in the duodenal ulcer patients than in their siblings or controls and less rapid progression of body gastritis. The overall progression of antral and body gastritis was similar in DU siblings and their controls, but a dichotomy in the mean antral gastritis score of DU sibships was found, indicating high and low antral gastritis liability subgroups. The mean score of DU sibships having a mean age of less than 50 years behaved dynamically like DU patients, while the mean scores of sibships with a higher mean age had a low liability to develop antral gastritis. Most duodenal ulcer siblings who themselves had a duodenal ulcer, ulcer scar or duodenitis were found in the "high antral gastritis liability" subgroup.

Entities:  

Mesh:

Year:  1983        PMID: 6642406

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.

Authors:  Shoko Fujiwara; Yoshinori Morita; Takashi Toyonaga; Fumi Kawakami; Tomoo Itoh; Masaru Yoshida; Hiromu Kutsumi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

Review 2.  Gastric atrophy, diagnosing and staging.

Authors:  Hala M T El-Zimaity
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

3.  Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.

Authors:  S Mossi; B Meyer-Wyss; E L Renner; H S Merki; G Gamboni; C Beglinger
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

4.  Helicobacter pylori and Zollinger-Ellison syndrome.

Authors:  Z A Saeed; D J Evans; D G Evans; M J Cornelius; P N Maton; R T Jensen; D Y Graham
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

5.  Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project.

Authors:  Richard F Harvey; J Athene Lane; Liam J Murray; Ian M Harvey; Jenny L Donovan; Prakash Nair
Journal:  BMJ       Date:  2004-05-04

6.  Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease.

Authors:  Rahul S Mhaskar; Izurieta Ricardo; Azizan Azliyati; Rajaram Laxminarayan; Bapaye Amol; Walujkar Santosh; Kwa Boo
Journal:  J Glob Infect Dis       Date:  2013-04

7.  The Helicobacter pylori duodenal ulcer promoting gene, dupA in China.

Authors:  Zhiyu Zhang; Qing Zheng; Xiaoyu Chen; Shudong Xiao; Wenzhong Liu; Hong Lu
Journal:  BMC Gastroenterol       Date:  2008-10-25       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.